GLP-1 and Apelin Dual Agonist Shows Promise in Parkinson's Mouse Model | Retatrutide News

A GLP-1/apelin dual receptor agonist shows neuroprotective effects in a Parkinson's disease mouse model. This finding may broaden the therapeutic scope ...
Clinical Trials · October 12, 2026